LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 117 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26 | -50.0% | 17,521 | -60.6% | 0.00% | -57.1% |
| Q4 2022 | $52 | -99.5% | 44,442 | +343.2% | 0.01% | +600.0% |
| Q3 2022 | $11,000 | -47.6% | 10,028 | -25.1% | 0.00% | -50.0% |
| Q2 2022 | $21,000 | -86.4% | 13,380 | -75.3% | 0.00% | -86.7% |
| Q2 2021 | $154,000 | +305.3% | 54,131 | +34.3% | 0.02% | +114.3% |
| Q3 2020 | $38,000 | -44.1% | 40,318 | -48.3% | 0.01% | -12.5% |
| Q2 2020 | $68,000 | – | 78,042 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,005,379 | $28,160,000 | 3.29% |
| Defender Capital, LLC. | 4,416,590 | $3,657,000 | 2.67% |
| Prescott General Partners LLC | 1,851,851 | $1,534,000 | 0.13% |
| Laidlaw Wealth Management LLC | 107,379 | $89,000 | 0.06% |
| Northeast Financial Consultants Inc | 523,756 | $434,000 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $37,000 | 0.04% |
| DAFNA Capital Management LLC | 95,000 | $79,000 | 0.03% |
| Summit X, LLC | 30,700 | $25,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 529,039 | $438,000 | 0.01% |
| Keudell/Morrison Wealth Management | 10,105 | $8,000 | 0.01% |